Antiviral effects and mechanisms of chlorogenic acid against SGIV and NNV infection

Read full text Summarise with VIRAT
Authors: Jinpeng Chen, Hannan Gong, Lifang Cao, Qiwei Qin, Min Yang, Shina Wei
Cited by: 0
References: 58

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Singapore grouper iridovirus (SGIV) and nervous necrosis virus (NNV) are major viral pathogens in grouper aquaculture, for which validated and practically applicable prophylactic or therapeutic strategies remain limited. Chlorogenic acid (CGA), the primary bioactive component in herbal medicines such as honeysuckle ( Lonicera japonica ), exhibits broad-spectrum antiviral activity. This study investigated the antiviral efficacy of CGA against SGIV and NNV both in vitro and in vivo , and explored its underlying mechanisms. Results demonstrated that CGA significantly suppressed transcriptional levels of SGIV genes, including major capsid protein (MCP), VP19, and LITAF, reduced SGIV-MCP protein expression and lowered the viral titer of SGIV. Concurrently, CGA inhibited the transcription of the NNV capsid protein (CP) gene and reduced NNV-CP protein expression and lowered the viral titer of NNV. Further analysis revealed that CGA markedly inhibited the formation of Lipid droplets (LDs), downregulated fatty acid synthesis-related genes (ACC1, FASN, SCD1) and promoted ATGL expression. Additionally, CGA significantly reduced transcriptional levels of NOD-like receptor family pyrin domain containing 3 (NLRP3), inflammasome-associated genes (NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC) and Caspase-1) and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8). Western blot analysis of autophagy-related proteins indicated that CGA substantially inhibited Autophagy-related protein 5 (ATG5) and Beclin1 expression and decreased the microtubule-associated protein 1 A/1B-light chain 3 (LC3)-II/LC3-I ratio. In in vivo challenge experiments, CGA administered intraperitoneally at 500 mg/kg significantly enhanced survival after SGIV and NNV infection. qRT-PCR further demonstrated that CGA pretreatment markedly decreased viral gene expression in brain, liver, and spleen tissues at 24 and 48 h post-infection. Collectively, these findings suggest that CGA exhibits antiviral activity against SGIV and NNV infections and may represent a potential candidate for antiviral intervention.

Fields of Study & Subjects

Aquaculture disease management and microbiota interferon and immune responses Aquaculture Nutrition and Growth

Publication details

Journal / source
Aquaculture Reports
Volume
48
Pages
103541–103541
Publication date
25 March 2026
Language
EN